Skip to main content Skip to section navigation Skip to footer
chevron_left Back to Envoymedical.com
Envoy Medical, Inc. IR Overview
  • Investors
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Information
    • Company Profile
    • Executive Team
    • Contacts
    • FAQ
  • Financial Information
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • chevron_leftBack to Envoymedical.com

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Dec 4, 2025 8:00 am EST
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient
Dec 2, 2025 8:00 am EST
Envoy Medical Announces the Grant of Its 40th U.S. Patent
Nov 20, 2025 8:00 am EST
Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery
Nov 18, 2025 8:00 am EST
Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial
Nov 10, 2025 8:00 am EST
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results
Nov 4, 2025 8:00 am EST
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial
Oct 29, 2025 8:00 am EDT
Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant
Oct 27, 2025 8:00 am EDT
Envoy Medical Receives Positive Listing Determination from NASDAQ
Oct 23, 2025 8:00 am EDT
Envoy Medical to Present at the Virtual Technology Investor Conference on October 28th
Oct 9, 2025 4:05 pm EDT
Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
©2025 Envoy Medical, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement